Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05564793Not ApplicableRecruiting

Improving CRT Outcome With Non-Invasive Cardiac Mapping

Role: collaborator

NCT04190641Not ApplicableCompleted

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

Role: collaborator

NCT04192474Not ApplicableCompleted

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Role: collaborator

All 3 trials loaded